Long-Acting Ivabradine; Personalized DAPT Strategy Flops; Meth and Heart Disease

Long-Acting Ivabradine; Personalized DAPT Strategy Flops; Meth and Heart Disease

August 3, 2022 0 By Jennifer Walker

A long-acting formulation of ivabradine improved heart function in patients with heart failure with reduced ejection fraction, the FIRST trial showed. (Journal of the American College of Cardiology)

Nature looks at the state of research on cardiovascular problems after SARS-CoV-2 infection.

Even before the COVID-19 pandemic, young adults reported a high prevalence of chronic conditions such as obesity and hypertension, according to a CDC study. (Morbidity and Mortality Weekly Report)

For people with pulmonary hypertension and heart failure with preserved ejection fraction (HFpEF), the vasodilator riociguat (Adempas) improved cardiac output in a phase IIb trial. (European Heart Journal)

Black people with low vitamin D levels were more prone to left ventricular concentric remodeling and HFpEF in the Jackson Heart Study. (Journal of Cardiac Failure)

Users of antiplatelets and beta-blockers appeared to be more susceptible to heart attacks triggered by hot weather. (Nature Cardiovascular Research)

A personalized approach to dual antiplatelet therapy (DAPT) de-escalation after acute coronary syndrome did not pan out. (Circulation: Cardiovascular Interventions)

Improvement of left ventricular ejection fraction soon after transcatheter aortic valve replacement was a good sign for 5-year outcomes. (JAMA Cardiology)

Low-molecular-weight heparin was an effective treatment for radial artery occlusion after transradial coronary catheterization, a small trial found. (JACC: Cardiovascular Interventions)

Siemens Healthineers said the FDA cleared the Artis icono ceiling angiography system, which features a flexible design and simplified cabling for faster cone beam CT acquisitions.

Some people with severe primary mitral regurgitation fit profiles that are more amenable to mitral valve surgery. (Heart)

Methamphetamines were associated with a similar magnitude of risk for cardiovascular disease as alcohol and cocaine. (Journal of the American Heart Association)

Can alcohol consumption increase coronary artery calcification but reduce coronary heart disease? (European Journal of Preventive Cardiology)

Early data support ultra-low-temperature cryoablation for atrial fibrillation. (JACC: Clinical Electrophysiology)

Artificial intelligence showed promise in identifying eligible candidates for stroke thrombectomy, according to a report from the Society of NeuroInterventional Surgery.

Many stroke survivors are not getting the DAPT recommended by guidelines for secondary prevention. (JAMA Network Open)

A mouse study showed that certain T cells may provide neuroprotection in stroke. (Journal of Clinical Investigation)

A bill to authorize more spending on heart disease in South Asian Americans passed the House. (Cardiovascular Business)

A New Jersey cardiologist was sentenced to 30 months in prison for unlawful oxycodone prescribing, the Department of Justice reported.

  • author['full_name']

    Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine. Follow